|
||
J. Cell Biol.,
Volume 143, Number 6, December 14, 1998 1647-1659
and hVPS34
Phosphatidylinositol 3'-Kinases in Vesicular Trafficking,
Regulation of the Actin Cytoskeleton, and Mitogenesis
Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York 10461
We have examined the roles of the p85/
p110
and hVPS34 phosphatidylinositol (PI) 3'-kinases
in cellular signaling using inhibitory isoform-specific
antibodies. We raised anti-hVPS34 and anti-p110
antibodies that specifically inhibit recombinant hVPS34
and p110
, respectively, in vitro. We used the antibodies to study cellular processes that are sensitive to low-dose wortmannin. The antibodies had distinct effects
on the actin cytoskeleton; microinjection of anti-p110
antibodies blocked insulin-stimulated ruffling, whereas
anti-hVPS34 antibodies had no effect. The antibodies
also had different effects on vesicular trafficking. Microinjection of inhibitory anti-hVPS34 antibodies, but
not anti-p110
antibodies, blocked the transit of internalized PDGF receptors to a perinuclear compartment,
and disrupted the localization of the early endosomal protein EEA1. Microinjection of anti-p110
antibodies, and to a lesser extent anti-hVPS34 antibodies, reduced the rate of transferrin recycling in CHO cells.
Surprisingly, both antibodies inhibited insulin-stimulated DNA synthesis by 80%. Injection of cells with antisense oligonucleotides derived from the hVPS34 sequence also blocked insulin-stimulated DNA synthesis,
whereas scrambled oligonucleotides had no effect. Interestingly, the requirement for p110
and hVPS34 occurred at different times during the G1-S transition.
Our data suggest that different PI 3'-kinases play distinct regulatory roles in the cell, and document an unexpected role for hVPS34 during insulin-stimulated mitogenesis.
This article has been cited by other articles:
|
|